Company intelligence / Profile preview

GenoSafe

Évry-Courcouronnes, Île-de-France, Francegenosafe.com ↗

Ownership: Private
Employees: ~34
Development stage: Other

Overview

GenoSafe has contributed to nearly 90 clinical trials, analyzed ~30,000 preclinical samples since 2008, and ~10,000 patient samples since 2015. It provides GLP/GCP-compliant analytical services for gene/cell therapies and innovative biologics. The company continues to expand its laboratory capacity to meet growing demand in the pharmaceutical field

Therapeutic areas: Rare DiseasesOther
Modalities: Gene therapyCell therapyVaccine (including DNA/RNA-based)Recombinant proteinMonoclonal antibodySmall molecule (as part of analytical services for biotherapeutics)
Industry: Contract Research Organization

Beyond the preview

Go deeper on GenoSafe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenoSafe.

Explore the full profile